Addiction Institute at Mount Sinai

The Addiction Institute at Mount Sinai within the Behavioral Health System provides comprehensive and personalized care for patients with alcohol, substance, and behavioral (e.g., food and gambling) addictions.

Meet Our Team

Yasmin Hurd, PhD

Director, Addiction Institute at Mount Sinai

Timothy K Brennan, MD

Director of Addiction Services, AIMS - West/St. Luke's

Director of Addiction Services, AIMS - Beth Israel

Annie Levesque, MD

Medical Director, AIMS - West/St. Luke's

Don C Des Jarlais, PhD

Director, Division of Epidemiology and Health Service Research, Mount Sinai Beth Israel

Uraina Clark, PhD

Assistant Professor, Neurology

Vilma Gabbay, MD

Chief, Pediatric Mood and Anxiety Disorders Program

Igor Galynker, MD

Director, Family Center for Bipolar Disorder, Mount Sinai Beth Israel

Rita Z Goldstein, PhD

Chief, Neuropsychoimaging of Addiction and Related Conditions (NARC) Research

Thomas B Hildebrandt, PsyD

Associate Professor of Psychiatry

Iliyan Ivanov, MD

Medical Director, Comprehensive Adolescent Rehabilitation and Education services program, Mount Sinai West

Nelly Alia-Klein, PhD

Co-Chief, Neuropsychoimaging of Addiction and Related Conditions (NARC) Research Program

David Lehman, MD

ASSISTANT PROFESSOR

Andrew N Merling, PhD

ASSISTANT PROFESSOR

ANNA M OPRESCU

Project Manager

David Perlman, MD

Associate Chief, Infectious Diseases, Mount Sinai Beth Israel

Joseph S Ruggiero, PhD

Associate Director, Addiction Treatment Services, Mount Sinai Beth Israel, Mount Sinai St. Luke’s, Mount Sinai West

Edwin Salsitz, MD

Medical Director, Division of Chemical Dependency, Mount Sinai Beth Israel

Shilpa R Taufique, PhD

Director, CARES, Child and Family Institute; Director, Education and Training in Child and Adolescent Psychology

Anil A Thomas, MD

ASSISTANT PROFESSOR

Assistant Medical Director, Methadone Maintenance Treatment Program, Mount Sinai Beth Israel

Faye Chao, MD

ASSISTANT PROFESSOR

Muhammad Parvaz, PhD

ASSISTANT PROFESSOR

An-Li Wang, PhD

ASSISTANT PROFESSOR

Featured Labs

Hurd Lab

Molecular Neuropsychopharmacology

Goldstein & Alia-Kelin Lab

Nestler Lab

Clark Laboratory

Devi Laboratory

Neuropeptides and their receptors, opiate receptor signal transduction, and narcotic addiction

Goate Laboratory

Han Laboratory

Cellular Neurophysiology

Kenny Laboratory

Behavioral and Molecular Neuroscience

Russo Laboratory

Schaefer Laboratory

Slesinger Laboratory

Zachariou Laboratory

Latest Publications

David C. Perlman and Ashly E. Jordan
Considerations for the Development of a Substance-Related Care and Prevention Continuum Model

Bagot RC, Cates HM, Purushothaman I, Lorsch ZS, Walker DM, Wang J, Huang X, Schlüter OM Maze I, Peña CJ, Heller EA, Issler O, Wang M, Song WM, Stein JL, Liu X, Doyle MA, Scobie KN, Sun HS, Neve RL, Geschwind D, Dong Y, Shen L, Zhang B, Nestler EJ.
Circuit-wide Transcriptional Profiling Reveals Brain Region-Specific Gene Networks Regulating Depression Susceptibility. Neuron. 2016 May 11. pii: S0896-6273(16)30074-5. doi: 10.1016/j.neuron.2016.04.015

Bassir Nia, A. et al.
Psychiatric comorbidity associated with synthetic cannabinoid use compared to cannabis

Chen Z, Kenny PJ.
Running on Empty: Leptin Signaling in VTA Regulates Reward from Physical Activity. Cell Metabolism. 2015 Oct 6; 22(4):540-1.doi: 10.1016/j.cmet.2015.09.021

Clark US, Sweet LH, Morgello S, Philip NS, Cohen RA. (in press).
High early life stress and aberrant amygdala activity: Risk factors for elevated neuropsychiatric symptoms in HIV+ adults. Brain Imaging and Behavior

Friedman AK, Juarez B, Ku SM, Zhang H, Calizo RC, Walsh JJ, Chaudhury D, Zhang S, Hawkins A, Dietz DM, Murrough JW, Ribadeneira M, Wong EH, Neve RL, Han MH.
KCNQ channel openers reverse depressive symptoms via an active resilience mechanism

Golden SA, Heshmati M, Flanigan M, Christoffel DJ, Guise K, Pfau ML, Aleyasin H, Menard C, Zhang H, Hodes GE, Bregman D, Khibnik L, Tai J, Rebusi N, Krawitz B, Chaudhury D, Walsh JJ, Han MH, Shapiro ML, Russo SJ.
Basal forebrain projections to the lateral habenula modulate aggression reward. Nature. 2016 Jun 29;534(7609):688-92. doi: 10.1038/nature18601

View All Publications

Contact Us

Mount Sinai Addiction Treatment Services

Mount Sinai Beth Israel
Tel: 212-256-2623

Mount Sinai St. Luke’s and Mount Sinai West
Tel: 212-523-6491

Mount Sinai Clinical Addiction Research

Tel: 212-824-9361
AIMS.Research@mssm.edu

Connect With Us

Take Our Surveys

Addiction Institute at Mount Sinai Survey

Medical Marijuana Clinician Survey